News

Innovation alliance unveils new name and strategic plan for Western Virginia

A strategic alliance has a new name — Verge — and a new vision of acting as the front door for an innovation economy that stretches from Lynchburg to the New River Valley.

Formed last year, the alliance is a joint mission of the Valleys Innovation Council, the Roanoke-Blacksburg Technology Council and the Regional Accelerator and Mentoring Program, known as RAMP.

At a virtual news conference Monday, organizers said the unified strength of the three organizations will help solidify connections and better leverage emerging opportunities for the region’s technologists, innovators and entrepreneurs.

Verge will focus on the technology and life sciences innovation ecosystem in the GO Virginia Region 2, a sprawling span of the state that includes the Roanoke and New River valleys, the Alleghany Highlands and the Lynchburg region.

“What is happening in technology in this part of Virginia is really exciting,” CEO Greg Feldmann said in a statement.

“By aligning the efforts of three distinct but synergistic entities, we will all more effectively develop external resourcing, more efficiently implement new programs ensuring each reaches the right audiences at the right moments and in the right contexts to provide maximum value.

“It’s all about comprehensively supporting the many people and organizations who are investing in and shaping the economic future of our region.”

While collaborating in the newly defined joint mission, the three organizations will continue their day-to-day operations under the same leadership.

Recent News

11/30/2023

ATCC Announces Award from NIAID to Consolidate its BEI Resources and NIH HIV Reagent Programs

ATCC, the world’s premier biological materials management and standards organization, today announced a seven-year contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to continue the management of the BEI Resources Program. NIAID has made an initial award of over $21.5 million, with further funding

11/30/2023

Acclinate Collaborates with Merck to Increase Clinical Trial Diversity

Acclinate, an expert in health equity through inclusive research, is collaborating with Merck, known as MSD outside the United States and Canada, to help increase participation by members of the Black/African American community in Merck’s oncology clinical studies. “We’re proud to be working with Merck because being a champion for health equity through inclusive research

11/27/2023

cultivate(MD) Capital Funds LP Announces Investment into Nanochon

cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage medical device companies with innovative technologies, announced today that they have made a significant investment into Nanochon, a Washington, D.C.—based regenerative cartilage innovator. Nanochon develops solutions utilized by sports medicine physicians to treat active patients requiring cartilage restoration.  Nanochon’s Chondrograft™ replaces lost or damaged